Journal
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 34, Issue 1, Pages -Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09546634.2023.2251622
Keywords
Atopic dermatitis; consensus; biologics; dupilumab; JAK-inhibitor; treatment
Categories
Ask authors/readers for more resources
Atopic dermatitis (AD) is a chronic-relapsing inflammatory skin disorder characterized by intense itching and eczematous lesions that have a negative impact on quality of life. Guidelines for managing moderate-to-severe AD in Qatar have been developed by a panel of experts using the Delphi technique. These guidelines offer a comprehensive and pragmatic approach to assist healthcare professionals in making clinical decisions in Qatar.
Atopic dermatitis (AD), a chronic-relapsing inflammatory skin disorder, manifests with intense itching and eczematous lesions impairing quality of life. A heterogeneous population, and regional clinical practices for treating AD warrant the development of guidelines in Qatar. Therefore, guidelines for the management of moderate-to-severe AD in Qatar have been developed and discussed. Experts, including dermatologists and immunologists, used the Delphi technique for developing guidelines. Consensus was defined as & GE;75% agreement or disagreement. AD is highly prevalent in primary and tertiary dermatology centers. AD-associated foot eczema and psoriasiform eczema are more frequent in Qatar than in Europe or USA. SCORing Atopic Dermatitis Index quantifies disease severity and itch. Dermatology Life Quality Index assesses the quality of life. Atopic Dermatitis Control Tool assesses long-term disease control. Moderate-severe AD benefits from new topicals like Janus-kinase-inhibitors or PDE4-inhibitors combined with phototherapy. Currently approved systemic agents are dupilumab, baricitinib, abrocitinib, and upadacitinib. New anti-IL-13 and anti-IL-31 therapies will soon be available. Patient education, allergy testing, and comorbidity consideration are critical in the management of AD. The expert panel established a comprehensive and pragmatic approach to managing moderate-to-severe AD, thereby assisting clinical decision-making for healthcare professionals in Qatar.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available